Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study

Overview of attention for article published in Annals of Surgical Oncology, May 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 24,092 followers.

RT @dr_samehhany81: Short-Course Radiotherapy Followed by neoadj chemotherapy and Subseq Radical ttt in Stage IV Rectal Ca @SWexner https:/…

RT @dr_samehhany81: Short-Course Radiotherapy Followed by neoadj chemotherapy and Subseq Radical ttt in Stage IV Rectal Ca @SWexner https:/…

RT @dr_samehhany81: Short-Course Radiotherapy Followed by neoadj chemotherapy and Subseq Radical ttt in Stage IV Rectal Ca @SWexner https:/…

Short-Course Radiotherapy Followed by neoadj chemotherapy and Subseq Radical ttt in Stage IV Rectal Ca @SWexner https://t.co/tgMaOot0Ns